Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

The announcement of the deal marked the end of the Metsera bidding war between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button